Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Maxim notified of patent allowance for MaxVax technology

March 20, 1997

Pharmacokinetic model described for BMS-188667

March 18, 1997

First live oral cholera vaccine approved in Canada

March 13, 1997

Activated immunoglobulins reported by Nippon Zoki

March 12, 1997

Positive preliminary results for rotavirus vaccine

March 7, 1997

SangStat receives European patent for Xenoject drugs

March 5, 1997

WF-10 undergoes further clinical studies for AIDS

March 5, 1997

Novel class of immunosuppressants disclosed by Novartis

March 4, 1997

Optivax phase I results reported at AAAI/AAI/CIS meeting

Feb. 27, 1997

Immunoregulatory protein discovered by Boehringer Mannheim

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...